Jagriti Bhatia

Jagriti Bhatia

Auto-generated profile, based on publicly available information

Jagriti Bhatia

Department of Pharmacology, Cardiovascular Research Laboratory All India Institute of Medical Sciences New Delhi India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KSKapil Suchal
Kapil Suchal
SMSalma Malik
Salma Malik
SKSana Khan
Sana Khan
RKRajiv Rajiv Kumar
Rajiv Rajiv Kumar
SGSameer Goyal
Sameer Goyal
DADharamveer Singh Arya
Dharamveer Singh Arya
There is growing evidence that chronic hyperglycemia leads to the formation of advanced glycation end products (AGEs) which exerts its effect via interaction with the receptor for advanced glycation end products (RAGE). AGE-RAGE activation results in oxidative stress and inflammation. It is well known that this mechanism is involved in the pathogenesis of cardiovascular disease in diabetes. Kaempferol, a dietary flavonoid, is known to possess antioxidant, anti-apoptotic, and anti-inflammatory activities. However, little is known about the effect of kaempferol on myocardial ischemia-reperfusion (IR) injury in diabetic rats. Diabetes was induced in male albino Wistar rats using streptozotocin (70 mg/kg; i.p.), and rats with glucose level >250 mg/dL were considered as diabetic. Diabetic rats were treated with vehicle (2 mL/kg; i.p.) and kaempferol (20 mg/kg; i.p.) daily for a period of 28 days and on the 28th day, ischemia was produced by one-stage ligation of the left anterior descending coronary artery for 45 min followed by reperfusion for 60 min. After completion of surgery, rats were sacrificed and the heart tissue was processed for biochemical, morphological, and molecular studies. Kaempferol pretreatment significantly reduced hyperglycemia, maintained hemodynamic function, suppressed AGE-RAGE axis activation, normalized oxidative stress, and preserved morphological alterations. In addition, there was decreased level of inflammatory markers (tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and NF-κB), inhibition of active c-Jun N-terminal kinase (JNK) and p38 proteins, and activation of Extracellular signal regulated kinase 1/2 (ERK1/2) a prosurvival kinase. Furthermore, it also attenuated apoptosis by reducing the expression of pro-apoptotic proteins (Bax and Caspase-3), Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells, and increasing the level of anti-apoptotic protein (Bcl-2). In conclusion, kaempferol attenuated myocardial ischemia-reperfusion injury in diabetic rats by reducing AGE-RAGE/ mitogen activated protein kinase (MAPK) induced oxidative stress and inflammation.

1 October 2017 in Phytomedicine
Verified
Journal Article
Closed access
ATAmeesha Tomar
Ameesha Tomar
SVSwati Vasisth
Swati Vasisth
SKSana Irfan Khan
Sana Irfan Khan
SMSalma Malik
Salma Malik
TNTapas Chandra Nag
Tapas Chandra Nag
JBJagriti Bhatia
Jagriti Bhatia

1 January 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
NGNanda Gamad
Nanda Gamad
SMSalma Malik
Salma Malik
KSKapil Suchal
Kapil Suchal
SVSwati Vasisht
Swati Vasisht
ATAmeesha Tomar
Ameesha Tomar
JBJagriti Bhatia
Jagriti Bhatia

1 March 2019 in Phytomedicine
Verified
Journal Article
Closed access
SGShanky Garg
Shanky Garg
RMRajiv Kumar Malhotra
Rajiv Kumar Malhotra
SKSana Irfan Khan
Sana Irfan Khan
SSSatyaki Sarkar
Satyaki Sarkar
PSPn Susrutha
Pn Susrutha
DADharamveer Singh Arya
Dharamveer Singh Arya

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SKSana Irfan Khan
Sana Irfan Khan
RMRajiv Kumar Malhotra
Rajiv Kumar Malhotra
NRNeha Rani
Neha Rani
ASAnil Kumar Sahu
Anil Kumar Sahu
ATAmeesha Tomar
Ameesha Tomar
JBJagriti Bhatia
Jagriti Bhatia
Xanthine oxidase and xanthine dehydrogenase have been implicated in producing myocardial damage following reperfusion of an occluded coronary artery. We investigated and compared the effect of febuxostat and allopurinol in an experimental model of ischemia‐reperfusion (IR) injury with a focus on the signaling pathways involved. Male Wistar rats were orally administered vehicle (CMC) once daily (sham and IR + control), febuxostat (10 mg/kg/day; FEB10 + IR), or allopurinol (100 mg/kg/day; ALL100 + IR) for 14 days. On the 15th day, the IR‐control and treatment groups were subjected to one‐stage left anterior descending (LAD) coronary artery ligation for 45 minutes followed by a 60‐minute reperfusion. Febuxostat and allopurinol pretreatment significantly improved cardiac function and maintained morphological alterations. They also attenuated oxidative stress and apoptosis by suppressing the expression of proapoptotic proteins (Bax and caspase‐3), reducing TUNEL‐positive cells, and increasing the level of antiapoptotic proteins (Bcl‐2). The MAPK‐based molecular mechanism revealed suppression of active JNK and p38 proteins concomitant with the rise in ERK1/ERK2, a prosurvival kinase. Additionally, a reduction in the level of inflammatory markers (TNF‐α, IL‐6, and NF‐κB) was also observed. The changes observed with febuxostat were remarkable in comparison with those observed with allopurinol. Febuxostat protects relatively better against IR injury than allopurinol by suppressing inflammation and apoptosis mediating the MAPK/NF‐κBp65/TNF‐α pathway.

13 December 2019 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
ATAmeesha Tomar
Ameesha Tomar
SKSwati Kaushik
Swati Kaushik
SKSana Irfan Khan
Sana Irfan Khan
KBKhushboo Bisht
Khushboo Bisht
TNTapas Chandra Nag
Tapas Chandra Nag
JBJagriti Bhatia
Jagriti Bhatia